The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Primary Hyperoxaluria
Abstract
The primary hyperoxalurias are a group of autosomal recessive disorders of endogenous oxalate overproduction. This review discusses the major biochemical, genetic, and therapeutic advances that have led to a better understanding of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion
Mulay, S. R., Kulkarni, O. P., Rupanagudi, K. V., Migliorini, A., Darisipudi, M. N., Vilaysane, A., Muruve, D., Shi, Y., Munro, F., Liapis, H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63679 · Cited by 468
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment
Cochat, P., Hulton, S.-A., Acquaviva, C., Danpure, C. J., Daudon, M., De Marchi, M., Fargue, S., Groothoff, J., Harambat, J., Hoppe, B., et al. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs078 · Cited by 335
Self-citationAn update on primary hyperoxaluria
Hoppe, B. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.113 · Cited by 312
Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type III
Belostotsky, R., Seboun, E., Idelson, G. H., Milliner, D. S., Becker-Cohen, R., Rinat, C., Monico, C. G., Feinstein, S., Ben-Shalom, E., Magen, D., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.07.023 · Cited by 233
Epidemiology of primary hyperoxaluria type 1
Cochat, P., Deloraine, A., Rotily, M., Olive, F., Liponski, I., Deries, N., & Pediatrique, O. B. O. T. S. D. N. A. T. S. D. N. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.supp8.3 · Cited by 186
Self-citationTransplantation Outcomes in Primary Hyperoxaluria
Bergstralh, E. J., Monico, C. G., Lieske, J. C., Herges, R. M., Langman, C. B., Hoppe, B., & Milliner, D. S. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03271.x · Cited by 182
Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome
van Woerden, C. S. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.2.273 · Cited by 180
Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene
Williams, E. L., Acquaviva, C., Amoroso, A., Chevalier, F., Coulter-Mackie, M., Monico, C. G., Giachino, D., Owen, T., Robbiano, A., Salido, E., et al. (2009) · Human Mutation · doi:10.1002/humu.21021 · Cited by 175
Self-citationHarambat, J., Fargue, S., Acquaviva, C., Gagnadoux, M.-F., Janssen, F., Liutkus, A., Mourani, C., Macher, M.-A., Abramowicz, D., Legendre, C., et al. (2010) · Kidney International · doi:10.1038/ki.2009.435 · Cited by 158
Self-citationCharacteristics and Outcomes of Children with Primary Oxalosis Requiring Renal Replacement Therapy
Harambat, J., van Stralen, K. J., Espinosa, L., Groothoff, J. W., Hulton, S., Čerkauskienė, R., Schaefer, F. S., Verrina, E. E., Jager, K. J., & Cochat, P. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07430711 · Cited by 154
Self-citation
Cited by
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
Garrelfs, S. F., Frishberg, Y., Hulton, S. A., Koren, M. J., O’Riordan, W. D., Cochat, P., Deschênes, G., Shasha-Lavsky, H., Saland, J. M., van’t Hoff, W. G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021712 · Cited by 531
Self-citationScott, L. J., & Keam, S. J. (2021) · Drugs · doi:10.1007/s40265-020-01463-0 · Cited by 292
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
Traber, G. M., & Yu, A.-M. (2023) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001234 · Cited by 291
Dutta, C., Avitahl-Curtis, N., Pursell, N., Larsson Cohen, M., Holmes, B., Diwanji, R., Zhou, W., Apponi, L., Koser, M., Ying, B., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.4 · Cited by 81
Nanoparticles and siRNA: a new era in therapeutics?
Pérez-Carrión, M. D., Posadas, I., & Ceña, V. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107102 · Cited by 48
Metadata
- Authors
- Cochat, P., & Rumsby, G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-08-15
- Volume
- 369
- Issue
- 7
- Pages
- 649-658
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4236938577
- Cited by
- 586
- References
- 32
- FWCI
- 22.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Primary Hyperoxaluria. https://app.cochat.ai/papers/10.1056/nejmra1301564
- The paper
- Cochat, P., & Rumsby, G. (2013). Primary Hyperoxaluria. New England Journal of Medicine. https://doi.org/10.1056/nejmra1301564
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
